[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Perspective_Tx Perspective Therapeutics Perspective Therapeutics posts on X about $catx, has been, germany, cest the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1684919119819251712/interactions)  - X Week XXX +248% - X Month XXXXX +430% - X Months XXXXX +126% - X Year XXXXX +958% ### Mentions: X [#](/creator/twitter::1684919119819251712/posts_active)  ### Followers: XXX [#](/creator/twitter::1684919119819251712/followers)  - X Week XXX +4.70% - X Month XXX +9.80% - X Months XXX +38% - X Year XXX +60% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1684919119819251712/influencer_rank)  ### Social Influence [#](/creator/twitter::1684919119819251712/influence) --- **Social category influence** [countries](/list/countries) **Social topic influence** [$catx](/topic/$catx) #2, [has been](/topic/has-been), [germany](/topic/germany), [cest](/topic/cest) ### Top Social Posts [#](/creator/twitter::1684919119819251712/posts) --- Top posts by engagements in the last XX hours "Were proud to be featured in @PharmaNowGlobal highlighting the first patient has been dosed in a new cohort of our Phase 1/2a trial exploring 212PbVMT01 in combination with a PD-1 inhibitor. For more details: $CATX #TargetedAlphaTherapy #oncology" [X Link](https://x.com/Perspective_Tx/status/1976395024179888295) [@Perspective_Tx](/creator/x/Perspective_Tx) 2025-10-09T21:11Z XXX followers, XXX engagements "We are on the ground at the European Society for Medical Oncology Congress 2025 (#ESMO25) in Berlin Germany We will be presenting updated interim results from our Phase 1/2a study of 212PbVMT--NET on Monday Oct. XX at 8:58AM CEST. For more: $CATX" [X Link](https://x.com/Perspective_Tx/status/1979995998479880556) [@Perspective_Tx](/creator/x/Perspective_Tx) 2025-10-19T19:40Z XXX followers, XXX engagements "Earlier today Perspective presented updated interim results from its Phase 1/2a study of 212PbVMT--NET at #ESMO25. There will be a conference call today to discuss the data at 8:30AM ET. For more details on the presentation and conference call: $CATX" [X Link](https://x.com/Perspective_Tx/status/1980236379188769246) [@Perspective_Tx](/creator/x/Perspective_Tx) 2025-10-20T11:35Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Perspective Therapeutics posts on X about $catx, has been, germany, cest the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence countries
Social topic influence $catx #2, has been, germany, cest
Top posts by engagements in the last XX hours
"Were proud to be featured in @PharmaNowGlobal highlighting the first patient has been dosed in a new cohort of our Phase 1/2a trial exploring 212PbVMT01 in combination with a PD-1 inhibitor. For more details: $CATX #TargetedAlphaTherapy #oncology"
X Link @Perspective_Tx 2025-10-09T21:11Z XXX followers, XXX engagements
"We are on the ground at the European Society for Medical Oncology Congress 2025 (#ESMO25) in Berlin Germany We will be presenting updated interim results from our Phase 1/2a study of 212PbVMT--NET on Monday Oct. XX at 8:58AM CEST. For more: $CATX"
X Link @Perspective_Tx 2025-10-19T19:40Z XXX followers, XXX engagements
"Earlier today Perspective presented updated interim results from its Phase 1/2a study of 212PbVMT--NET at #ESMO25. There will be a conference call today to discuss the data at 8:30AM ET. For more details on the presentation and conference call: $CATX"
X Link @Perspective_Tx 2025-10-20T11:35Z XXX followers, XXX engagements
/creator/x::Perspective_Tx